0001357019-14-000001.txt : 20140113 0001357019-14-000001.hdr.sgml : 20140113 20140113111541 ACCESSION NUMBER: 0001357019-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140113 DATE AS OF CHANGE: 20140113 EFFECTIVENESS DATE: 20140113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PLUROGEN THERAPEUTICS INC CENTRAL INDEX KEY: 0001357019 IRS NUMBER: 203893334 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-209854 FILM NUMBER: 14523731 BUSINESS ADDRESS: STREET 1: 2495 GENERAL ARMISTEAD AVENUE CITY: NORRISTOWN STATE: PA ZIP: 19403 BUSINESS PHONE: 6105393670 MAIL ADDRESS: STREET 1: 2495 GENERAL ARMISTEAD AVENUE CITY: NORRISTOWN STATE: PA ZIP: 19403 D 1 primary_doc.xml X0707 D LIVE 0001357019 PLUROGEN THERAPEUTICS INC 2495 GENERAL ARMISTEAD AVENUE NORRISTOWN PA PENNSYLVANIA 19403 6105393670 DELAWARE None None Corporation true Neal G. Koller 3724A Thomas Point Road Annapolis MD MARYLAND 21403 Executive Officer Director George T. Rodeheaver 845 Carlins Way Charlottesville VA VIRGINIA 22903 Executive Officer Director Adam J. Katz 3131 SW 98 Drive Gainesville FL FLORIDA 32608 Executive Officer Director James B. Farinholt Westham Green #7 300 North Ridge Road Richmond VA VIRGINIA 23229 Director Daniel Brody 503 Faulconer Drive Charlottesville VA VIRGINIA 22903 Director Wendy L. Yarno 60 Simmons Lane Sedona AZ ARIZONA 86531 Director Biotechnology Decline to Disclose 06b false 2013-12-27 false true true true The offering consists of Series B Convertible Preferred Stock and Warrants to acquire Series B Convertible Preferred Stock. false 50001 4125000 300000 3825000 The minimum investment amount is $50,001, provided that the Board in its discretion may accept lesser investment amounts. false 4 0 0 750000 true false PLUROGEN THERAPEUTICS INC /Neal G. Koller/ Neal G. Koller President and CEO 2014-01-09